Companies Making Progress!!
Webinar: WellSky – greater efficiency, safety for cell therapy labs
As the possibilities of cellular therapy continue to expand, you need a solution that can manage and document all the steps required for quality production so your lab can grow within a fast evolving, highly regulated industry. Learn how WellSky and Digi-Trax have teamed up to provide that solution. Join us for a free webinar on Nov 7, 9 AM GMT+10 (Nov 6, 5 PM US CDT). Register Now!
Arizona-based biotech startup BioLab Sciences announces patent for regenerative tissue therapy, MyOwn Skin™
SCOTTSDALE, Ariz., Oct. 24, 2018 — BioLab Sciences, an innovator in regenerative medicine technologies, announced its exclusively licensed technology for MyOwn Skin™, a painless, non-surgical procedure, which leverages a patient’s own skin to produce full-thickness skin grafts in 5-7 days.
Propagenix – Interview with the President and CEO, Brian Pollok, Ph.D.
Propagenix is a preclinical-stage platform technology company that is applying its unique technology to both internal and partnered cell therapy programs. The company is engaged in the development and commercialization of technology which originated from the laboratory of Dr. Richard Schlegel of Georgetown University. Headquartered in Rockville, Maryland, Progagenix was founded in 2014 by Brian Pollok, Ph.D.
Eppendorf presents first internally developed CO2 incubator
Hamburg, October 2018 — “Today’s cell culture requires more than technical solutions for optimized growth conditions and efficient contamination prevention,” says Eppendorf´s Business Manager for cell culture products Dr. Patrik Ferreira. “For several years, customers involved in Eppendorf´s development process have reported an increasing demand for devices that provide flexibility, support with increasing documentation demands and use natural resources sustainably.
Cell Care Therapeutics Raises $4.3 Million in Seed Funding
MONROVIA, Calif. — Cell Care Therapeutics, Inc., a biotechnology company whose mission is to advance stem-cell derived therapies in ophthalmology, announced the closing of a $4.3 million seed round investment from a syndicate of individual investors.
Sistemic & Cynata sign Global Service & License Agreement for the use of SistemPSCCheck™
Glasgow, UK; 22 October 2018 - Sistemic Ltd. has completed a Global Service and License Agreement for its SistemPSCCheck™ assay with the Australian stem cell and regenerative medicine company, Cynata Therapeutics. The agreement will see the use of the SistemPSCCheck™ assay for the assessment of residual pluripotent stem cells in Cynata’s current iPSC-derived MSC clinical candidate CYP-001, as well other planned iPSC-derived MSC products.
Forever Labs, Is It Worth $7,000 to Save Cells from Your Younger Self?
Forever Labs is one of the first companies worldwide to offer stem cell storage for adults. Interestingly, there is a prolific market for the storage of newborn tissues, including umbilical cord blood, umbilical tissue, and placental blood and tissue. However, storage for stem cells from adult tissues is extremely limited. Could it be worth $7,000 to store your stem cells before you (and they) get too old?
Exosome Companies | Tiny Exosomes, Enormous Potential
Exosomes are small vesicles ranging from 30-100nm in size that are found in nearly all eukaryotic fluids and facilitate a range of important cellular functions. Although exosomes were discovered more than 30 years ago, it was not until recently that the scientific community began to give credit to exosomes for a range of promising traits. This article profiles 15 companies that have emerged as technology leaders within this rapidly expanding industry.
What Is Multiple Sclerosis? | FAQs
Multiple sclerosis (MS) is a complex and long-lasting disease that causes damage to your brain and nerves. Multiple sclerosis occurs when your immune system attacks myelin, a fatty material that shields your nerve fibers. Learn more about multiple sclerosis treatment and how stem cells may help in treating this condition.
Can Asthma Treatment Be Achieved Through Stem Cell Therapy?
Progress with regenerative medicine is supporting the development of a new type of asthma treatment that has the potential to reduce asthma attacks and repair lung damage. One in every 12 people suffer from asthma, making cellular solutions to this disease of critical importance.
Cell Therapy Manufacturing Survey – Selection Criteria for Choosing a CMO Partner (50% Off)
In this 21-page, 50+ respondent survey, cell therapy manufacturing executives reveal when and why they choose to partner with a contact manufacturing organization (CMO). It reveals the selection criteria that cell therapy executives use, as well as their perspectives on manufacturing capacity, geography, pure-play versus hybrid CMOs, and much more. For the next 48 hours, you can claim it for 50% off (only $97).
Global Induced Pluripotent Stem Cell Industry Report 2018-19 [Recently Released, October 2018]
Recent years have seen major advances in clinical applications, production and differentiation technologies, and biobanking of iPSCs. Interest in the therapeutic applications of iPS cells arises from their use in drug development and discovery, toxicology screening, disease modeling, and cell transplantation. Claim this 146-page report to access critical 2018-19 data that reveals market size, segments, trends, future growth projections by product category, and the competitive advantages of dominant market competitors, including CDI (a Fujifilm company), Ncardia, ReproCELL (Stemgent), Axol Bioscience, and others.
AI
